Kidney Disease Clinical Trials

Showing 3241-3260 of 3,902 trials

Long-term Study in Patients With Chronic Kidney Disease and Hyperphosphatemia on Hemodialysis

NCT00892749

This is a multi-center, open-labeled, non-comparative study to examine the safety and efficacy of ASP1585 for long-term dosing in chronic kidney disease and hyperphosphatemia patients on hemodialysis.

Chronic Kidney DiseaseRenal DialysisRenal Insufficiency+1 more

Astellas Pharma Inc248 participantsStarted May 2009

Chugoku, Japan • Chūbu, Japan • Kansai, Japan +1 more locations

COMPLETEDPhase 3

A Phase 3 Study in Patients With Chronic Kidney Disease and Hyperphosphatemia on Peritoneal Dialysis

NCT01017276

This is a multi-center, open-labeled, non-comparative study to examine the safety and efficacy of ASP1585 in chronic kidney disease and hyperphosphatemia patients on peritoneal dialysis.

Chronic Kidney DiseaseRenal DialysisRenal Insufficiency

Astellas Pharma Inc35 participantsStarted Nov 2009

Chugoku, Japan • Chūbu, Japan • Kantou, Japan

COMPLETEDPhase 1/2

A Phase 1-2 Study of PRT-201 Administered in Chronic Kidney Disease (CKD) Patients

NCT00679991

PRT-201 is a protein that causes long lasting dilation of blood vessels when applied to the outside surface of the blood vessel. The purpose of this study is to determine if PRT-201, when applied to a limited segment of blood vessel immediately after surgery to create an arteriovenous fistula (AVF), is safe, dilates the blood vessel, and increases blood flow through the AVF.

Chronic Kidney Disease

Proteon Therapeutics66 participantsStarted Nov 2008

Indianapolis, Indiana, United States • Iowa City, Iowa, United States • Portland, Maine, United States +8 more locations

Long-term Study in Patients With Chronic Kidney Disease and Hyperphosphatemia on Hemodialysis

A Phase 3 Study in Patients With Chronic Kidney Disease and Hyperphosphatemia on Peritoneal Dialysis

A Phase 1-2 Study of PRT-201 Administered in Chronic Kidney Disease (CKD) Patients

Related Searches

Sutent Rechallenge In mRCC Patients

Changes in Adrenal Hormones During Adrenal Radiofrequency Ablation

Effect of the Inhibition of the Mammalian Target of Rapamycin on Metabolism and Exercise

The Effect of Nocturnal Haemodialysis on Arterial Stiffness

Frusemide Infusion for the Prevention of Deterioration in Renal Function Post Cardiac Surgery.

Sun Protection of Kidney Transplant Recipients

Specific Enteral Nutrition in Malnourished, Dialysis Patients With Chronic Kidney Disease. Efficacy, Safety, Quality of Life

Safety Study of Cord Blood-derived Cytokine-induced Killer Cells in Patients With Solid Tumor After Radical Resection

Short Term Spironolactone for Prevention of Acute Kidney Injury After Cardiac Surgery

Assessing Perceived Versus Actual Knowledge and Quality of Life in Pre-Dialysis Chronic Kidney Disease (CKD) Patients

Low Magnitude Mechanical Stimuli Effects on Bone Structure in ESRD

Plasma and Hemodynamic Markers During Hepatectomy

Pilot Study of Rapamycin as Treatment for Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Utility of Prolonged-release Pirfenidone in the Progression of Chronic Kidney Disease

Ticagrelor and Anti-inflammatory Effects

Biological, Pathological and Imagery Markers in the First-line Treatment of Metastatic Clear-cell Renal Cell Carcinoma

Kanagawa Valsartan Trial (KVT): Effects of Valsartan on Renal and Cardiovascular Disease